CY1110537T1 - Ενωσεις και μεθοδοι για την αγωγη της δυσλιπιδαιμιας - Google Patents
Ενωσεις και μεθοδοι για την αγωγη της δυσλιπιδαιμιαςInfo
- Publication number
- CY1110537T1 CY1110537T1 CY20091101151T CY091101151T CY1110537T1 CY 1110537 T1 CY1110537 T1 CY 1110537T1 CY 20091101151 T CY20091101151 T CY 20091101151T CY 091101151 T CY091101151 T CY 091101151T CY 1110537 T1 CY1110537 T1 CY 1110537T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methods
- unions
- disease education
- education
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Abstract
Αποκαλύπτονται ενώσεις τύπου I στον οποίο τα n, m, p, q, Υ, R1, R2, R3, R4, R5 και R6 είναι όπως ορίζονται εδώ και οι φαρμακευτικές συνθέσεις και μέθοδοι χρήσεως ως χρήσιμες για την αγωγή της αθηροσκληρώσεως και των συνεπειών της.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50973603P | 2003-10-08 | 2003-10-08 | |
EP04793889A EP1670768B1 (en) | 2003-10-08 | 2004-10-07 | Compounds and methods for treating dyslipidemia |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1110537T1 true CY1110537T1 (el) | 2015-04-29 |
Family
ID=34465112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20091101151T CY1110537T1 (el) | 2003-10-08 | 2009-11-05 | Ενωσεις και μεθοδοι για την αγωγη της δυσλιπιδαιμιας |
Country Status (25)
Country | Link |
---|---|
US (1) | US7749992B2 (el) |
EP (2) | EP1670768B1 (el) |
JP (1) | JP4773969B2 (el) |
KR (1) | KR20060085675A (el) |
CN (1) | CN1863778A (el) |
AT (1) | ATE442358T1 (el) |
AU (1) | AU2004282101A1 (el) |
BR (1) | BRPI0414186A (el) |
CA (1) | CA2537942A1 (el) |
CY (1) | CY1110537T1 (el) |
DE (1) | DE602004023100D1 (el) |
DK (1) | DK1670768T3 (el) |
EA (1) | EA200600737A1 (el) |
EC (1) | ECSP066484A (el) |
ES (1) | ES2332051T3 (el) |
HR (1) | HRP20090581T1 (el) |
IL (1) | IL173819A0 (el) |
MA (1) | MA28268A1 (el) |
MX (1) | MXPA06003927A (el) |
NO (1) | NO20062074L (el) |
PL (1) | PL1670768T3 (el) |
PT (1) | PT1670768E (el) |
SI (1) | SI1670768T1 (el) |
WO (1) | WO2005037796A1 (el) |
ZA (1) | ZA200602888B (el) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602005014955D1 (de) * | 2004-03-26 | 2009-07-30 | Lilly Co Eli | Verbindungen und verfahren zur behandlung von dyslipidämie |
JP2008504266A (ja) | 2004-06-24 | 2008-02-14 | イーライ リリー アンド カンパニー | 異脂肪血症を治療するための化合物及び方法 |
US7652023B2 (en) | 2005-11-23 | 2010-01-26 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US7790770B2 (en) * | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
AR077208A1 (es) | 2009-06-30 | 2011-08-10 | Lilly Co Eli | Derivados del acido trans-4-[[(5s)-5-[[[3,5-bis(trifluorometil) fenil] metil] (2-metil-2h-tetrazol-5-il) amino) -2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il) metil)-ciclohexancarboxilico y sus formas cristalinas, composiciones farmaceuticas que los comprenden, su uso para preparar un medicam |
CN103833636B (zh) * | 2014-03-31 | 2015-09-02 | 武汉武药制药有限公司 | 一种莫扎伐普坦中间体的合成方法 |
BR112018001707A2 (pt) * | 2015-07-31 | 2018-09-18 | Arena Pharm Inc | agonistas de receptor 5-ht2c e composições e métodos de uso |
CN110291383B (zh) * | 2017-02-23 | 2021-12-28 | 株式会社Ihi | Oh自由基检测探测器、oh自由基测定装置以及oh自由基测定方法 |
AR116798A1 (es) | 2018-10-24 | 2021-06-16 | VIIV HEALTHCARE UK Nº 5 LTD | Inhibidores de la replicación del virus de la inmunodeficiencia humana |
JP2023521460A (ja) | 2020-04-15 | 2023-05-24 | ビーブ、ヘルスケア、ユーケー、(ナンバー5)、リミテッド | ヒト免疫不全ウイルス複製の阻害剤 |
CN113636977B (zh) * | 2021-09-01 | 2022-12-20 | 温州大学 | 2-芳基苯并氮杂卓及其衍生物的合成方法 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2905909B2 (ja) * | 1991-04-19 | 1999-06-14 | 大塚製薬株式会社 | バソプレシン拮抗剤 |
TW270927B (el) * | 1992-10-16 | 1996-02-21 | Otsuka Pharma Co Ltd | |
US5484783A (en) * | 1994-03-24 | 1996-01-16 | Merrell Dow Pharmaceuticals Inc. | Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives |
DE69514912T2 (de) * | 1994-03-24 | 2000-10-05 | Merrell Pharma Inc | Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten |
DE69535486T2 (de) * | 1994-06-15 | 2008-04-10 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclische Verbindungen verwendbar als Vasopressin- oder Oxytocin-Modulatoren |
GB9523526D0 (en) * | 1995-11-17 | 1996-01-17 | Zeneca Ltd | Therapeutic compounds |
JPH09214746A (ja) | 1996-02-02 | 1997-08-15 | Ricoh Co Ltd | 画像出力システム及び画像形成装置 |
HRP970330B1 (en) | 1996-07-08 | 2004-06-30 | Bayer Ag | Cycloalkano pyridines |
DE19627431A1 (de) | 1996-07-08 | 1998-01-15 | Bayer Ag | Heterocyclisch kondensierte Pyridine |
DE19627430A1 (de) | 1996-07-08 | 1998-01-15 | Bayer Ag | Bicyclisch kondensierte Pyridine |
US6207671B1 (en) | 1996-07-08 | 2001-03-27 | Bayer Aktiengesellschaft | Cycloalkano-pyridines |
US6333349B1 (en) * | 1997-02-26 | 2001-12-25 | Aventis Pharma Deutschland Gmbh | Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them |
DE19709125A1 (de) | 1997-03-06 | 1998-09-10 | Bayer Ag | Substituierte Chinoline |
JPH10287662A (ja) | 1997-04-08 | 1998-10-27 | Kitasato Inst:The | Fo−5637a物質及びb物質並びにそれらの製造法 |
JP2959765B2 (ja) * | 1997-12-12 | 1999-10-06 | 日本たばこ産業株式会社 | 3−ピペリジル−4−オキソキナゾリン誘導体及びそれを含有してなる医薬組成物 |
US6197786B1 (en) | 1998-09-17 | 2001-03-06 | Pfizer Inc | 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
GT199900147A (es) | 1998-09-17 | 1999-09-06 | 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas. | |
US6147090A (en) * | 1998-09-17 | 2000-11-14 | Pfizer Inc. | 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines |
US6147089A (en) * | 1998-09-17 | 2000-11-14 | Pfizer Inc. | Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines |
HN2000000203A (es) * | 1999-11-30 | 2001-06-13 | Pfizer Prod Inc | Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas. |
CO5271716A1 (es) | 1999-11-30 | 2003-04-30 | Pfizer Prod Inc | Cristales de 4- carboxamino 1,2,3,4-tetrahidroquinolina 2- sustituida |
US6664522B2 (en) * | 2000-03-30 | 2003-12-16 | Homer L. Spencer | Method and apparatus for sealing multiple casings for oil and gas wells |
US7115279B2 (en) * | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
DK1383734T3 (da) * | 2001-04-30 | 2006-05-15 | Pfizer Prod Inc | Forbindelser, der er anvendelige som mellemprodukter til 4-aminoquinolinderivater |
CZ20033341A3 (cs) * | 2001-06-21 | 2004-10-13 | Pfizeráproductsáinc | Samoemulgující se kompozice inhibitorů přenosového proteinu cholesterylesteru |
DE10148436A1 (de) | 2001-10-01 | 2003-04-17 | Bayer Ag | Tetrahydrochinoline |
DE60322665D1 (de) * | 2002-02-01 | 2008-09-18 | Pfizer Prod Inc | Pharmazeutische darreichungsform mit gesteuerter freigabe eines cholesterylester-transferproteininhibitors |
EP2281849B1 (en) | 2002-07-01 | 2013-11-13 | Allnex Belgium, S.A. | Water-thinnable polymer precursors, their preparation and use |
PT1533292E (pt) | 2002-08-30 | 2007-05-31 | Japan Tobacco Inc | Compostos de dibenzilamina e sua utilização farmacêutica. |
JP2006508077A (ja) * | 2002-10-04 | 2006-03-09 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | 炎症疾患を治療するためのpgd2レセプタアンタゴニスト |
WO2004078730A2 (en) | 2003-03-04 | 2004-09-16 | Takasago International Corporation | Method for producing optically active amines |
US20040204450A1 (en) * | 2003-03-28 | 2004-10-14 | Pfizer Inc | Quinoline and quinoxaline compounds |
EP1670765A2 (en) | 2003-09-30 | 2006-06-21 | Pfizer Products Inc. | Cetp inhibitors and metabolites thereof |
DE602005014955D1 (de) * | 2004-03-26 | 2009-07-30 | Lilly Co Eli | Verbindungen und verfahren zur behandlung von dyslipidämie |
JP2008504266A (ja) * | 2004-06-24 | 2008-02-14 | イーライ リリー アンド カンパニー | 異脂肪血症を治療するための化合物及び方法 |
-
2004
- 2004-10-07 CN CNA2004800295407A patent/CN1863778A/zh active Pending
- 2004-10-07 PL PL04793889T patent/PL1670768T3/pl unknown
- 2004-10-07 BR BRPI0414186-5A patent/BRPI0414186A/pt not_active Application Discontinuation
- 2004-10-07 WO PCT/US2004/030907 patent/WO2005037796A1/en active Application Filing
- 2004-10-07 ES ES04793889T patent/ES2332051T3/es active Active
- 2004-10-07 MX MXPA06003927A patent/MXPA06003927A/es not_active Application Discontinuation
- 2004-10-07 JP JP2006533949A patent/JP4773969B2/ja not_active Expired - Fee Related
- 2004-10-07 AU AU2004282101A patent/AU2004282101A1/en not_active Abandoned
- 2004-10-07 KR KR1020067006837A patent/KR20060085675A/ko not_active Application Discontinuation
- 2004-10-07 SI SI200431294T patent/SI1670768T1/sl unknown
- 2004-10-07 EA EA200600737A patent/EA200600737A1/ru unknown
- 2004-10-07 DE DE602004023100T patent/DE602004023100D1/de active Active
- 2004-10-07 EP EP04793889A patent/EP1670768B1/en active Active
- 2004-10-07 EP EP09157118A patent/EP2098512A1/en not_active Withdrawn
- 2004-10-07 CA CA002537942A patent/CA2537942A1/en not_active Abandoned
- 2004-10-07 AT AT04793889T patent/ATE442358T1/de active
- 2004-10-07 DK DK04793889T patent/DK1670768T3/da active
- 2004-10-07 US US10/574,649 patent/US7749992B2/en not_active Expired - Fee Related
- 2004-10-07 PT PT04793889T patent/PT1670768E/pt unknown
-
2006
- 2006-02-20 IL IL173819A patent/IL173819A0/en unknown
- 2006-04-05 EC EC2006006484A patent/ECSP066484A/es unknown
- 2006-04-07 ZA ZA200602888A patent/ZA200602888B/en unknown
- 2006-05-03 MA MA28999A patent/MA28268A1/fr unknown
- 2006-05-08 NO NO20062074A patent/NO20062074L/no not_active Application Discontinuation
-
2009
- 2009-10-30 HR HR20090581T patent/HRP20090581T1/hr unknown
- 2009-11-05 CY CY20091101151T patent/CY1110537T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO20062074L (no) | 2006-05-08 |
ECSP066484A (es) | 2006-10-10 |
CN1863778A (zh) | 2006-11-15 |
DE602004023100D1 (de) | 2009-10-22 |
US7749992B2 (en) | 2010-07-06 |
ES2332051T3 (es) | 2010-01-25 |
PL1670768T3 (pl) | 2010-01-29 |
KR20060085675A (ko) | 2006-07-27 |
MA28268A1 (fr) | 2006-11-01 |
BRPI0414186A (pt) | 2006-10-31 |
MXPA06003927A (es) | 2008-02-07 |
ZA200602888B (en) | 2007-11-28 |
HRP20090581T1 (hr) | 2009-12-31 |
ATE442358T1 (de) | 2009-09-15 |
WO2005037796A1 (en) | 2005-04-28 |
EA200600737A1 (ru) | 2006-10-27 |
DK1670768T3 (da) | 2009-11-09 |
CA2537942A1 (en) | 2005-04-28 |
SI1670768T1 (sl) | 2010-01-29 |
JP2007508301A (ja) | 2007-04-05 |
AU2004282101A1 (en) | 2005-04-28 |
IL173819A0 (en) | 2006-07-05 |
EP2098512A1 (en) | 2009-09-09 |
EP1670768A1 (en) | 2006-06-21 |
JP4773969B2 (ja) | 2011-09-14 |
US20070254869A1 (en) | 2007-11-01 |
EP1670768B1 (en) | 2009-09-09 |
PT1670768E (pt) | 2009-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1110537T1 (el) | Ενωσεις και μεθοδοι για την αγωγη της δυσλιπιδαιμιας | |
CY2020012I2 (el) | Προφαρμακα των ενωσεων 2,4-πυριμιδινδιαμινης και οι χρησεις αυτων | |
NL301113I2 (nl) | Tucatinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout of solvaat | |
CY1110398T1 (el) | Ενωσεις για την αγωγη της δυσλιπιδαιμιας | |
MA29136B1 (fr) | Agents de potentialisation de recepteurs du glutamate | |
CY1111867T1 (el) | Ενωση ενεργοποιησης ppar και φαρμακευτικη συνθεση που περιεχει αυτη | |
SE0302811D0 (sv) | Novel compounds | |
CY1110835T1 (el) | Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c | |
NO2014009I2 (no) | Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser | |
CY1112124T1 (el) | Ενωσεις και μεθοδοι για τη θεραπεια δυσλιπιδαιμιας | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
EA200702347A1 (ru) | Способ получения глюкопиранозилзамещённых производных бензилбензола и промежуточных продуктов для их получения | |
CY1112862T1 (el) | Θραυσματα μονοσθενους αντισωματος χρησιμα ως θεραπευτικα | |
SE0400043D0 (sv) | New compounds | |
DE60314633D1 (de) | Substituierte 1,3-diphenylprop-2-en-1-on derivate, deren herstellung und anwendungen | |
ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
NO20054787D0 (no) | Indenderivater som farmasotiske midler | |
NO20062629L (no) | Oksazolderivater av tetrackliner | |
EA200602281A1 (ru) | Гетероарилсульфоны и сульфонамиды и их терапевтические применения | |
NO20063293L (no) | Farmasoytiske forbindelser | |
CY1107158T1 (el) | Νεα παραγωγα της ισοκινολινης, η μεθοδος παρασκευης τους και η χρηση τους για τη θεραπεια των διαταραχων του μελατονινεργικου συστηματος | |
SE0302755D0 (sv) | Novel compounds | |
CY1108865T1 (el) | Υποκατεστημενες 2,5-διαμινομευθυλο-1η-πυρρολες | |
CY1105981T1 (el) | Ενωσεις 5-πυριδυλ-1,3-αζολιου, μεθοδοι παρασκευης αυτων και χρηση αυτων |